Furthermore, after combined treatment, most tumor-infiltrating lymphocytes stained positively for granzyme B. These results are in accordance with a number of reports that demonstrated that tumor infiltration with effector immune cells is one of the most significant positive predictive markers for the success of various anticancer therapies [34, 35]. Here, GZMB is linked to neoplasm.